Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by newdaydawningon Mar 28, 2017 1:02pm

107 Views

Post# 26041170

Extending cash runway through warrants exercise

Depending on the news flow, TLT may be able to avoid another money raise if the SP exceeds $0.40 on a sustained basis. There are 14.2M warrants exercisable at $0.375 that, if exercised, would add more than $5M to the balance sheet. Further out, if TLT's SP trades above $0.60 on a sustained basis, that may prompt the conversion of 19M warrants priced @ $0.54. That would add another $10M to the balance sheet.

Bullboard Posts

Transportation technology stock secures second major contract in a week